CARS1 and neoplasm: A striking example is the release of EVs by chimeric antigen receptor (CAR) T-cells carrying surface CARs, which recognize and induce the death of tumor cells expressing CAR-specific tumor antigens (77).This innovative approach demonstrates the therapeutic potential of EVs in cancer.